Navigation Links
Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
Date:7/11/2013

MARKHAM, Ontario, July 11, 2013 /PRNewswire/ -- This morning Ensil Canada announced the exciting news that its scientific team of researchers and engineers have made a major breakthrough in the development of a revolutionary medical product that has the potential to help patients who suffer from mobility issues.

Ensil Canada has completed successful test results that show a proprietary communication device can be used to communicate with the brain and bypass the spine. This breakthrough meets the targets set by Ensil to have a prototype of a device by the end of 2013 for more comprehensive testing.

"We are very proud and confident that we have developed a product at our Ontario, Canada facilities that could help tens of thousands of people who suffer from mobility issues," said Farsad Kiani, CEO of Ensil Canada. "This is a phenomenal first step. It is our hope that we can bring this product to market, so that people can continue enjoying their day to day activities such as jogging, swimming and walking."

Today's announcement is one of the many areas of research by Ensil Canada to improve the lives of people across the world. Over the past three decades, Ensil Canada has made many positive breakthroughs and worked in the community to improve people's health and wellbeing. Recent work has included major advancements in the quality of the life of those whose their life has been affected by Stroke, Multiple Scoliosis, Spinal Cord injury or paralysis.

Ensil Canada focuses on enhancing mission critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's research and development divisions' mission is to develop new technologies or improve existing technologies through its own in-house research activities and resources.

Ensil Canada, a member of Ensil group of companies (www.ensil.ca), focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment.

Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities.

For further information please contact us at: info @ensil.com or visit us at www.ensil.ca.

This press release was issued through 24-7PressRelease.com.  For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Canada-based Radimetrics Announces Expansion to Scotland
3. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. VirtualScopics Receives Issuance of Influential Patent in Canada
7. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
8. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
9. Sensus Healthcare Announces Health Canada Approval
10. New Treatment For Obstructive Sleep Apnea Now Available In Canada
11. Integrated Marketing Company Expands Into Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):